News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 145–180
- Matches
- 776
- Sources here
- 14
- Companies here
- 13
Active search
776 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Charles River Labs SVP Michael Knell sells $1.73m in stock
Michael Knell, SVP, Finance and Chief Accounting Officer at Charles River Laboratories International (NASDAQ:CRL), sold 6,645 shares totaling approximately $1.73 million on August 6, 2026, with prices ranging from $258.53 to $265.17 per share. On the same day, he acquired 2,345 shares through stock …
Blink Charging: Charging Service Revenue Jumps 17% As Company Pulls Back From Lower-Margin Hardware Sales
Blink Charging's service revenue increased by 17% in the first half of 2026 as the company strategically shifted away from lower-margin hardware sales to focus on recurring charging and network revenue. This shift led to a 40% decrease in product revenue but significantly reduced …
Charles Schwab Trust Co Acquires New Shares in Mondelez International, Inc. $MDLZ
Charles Schwab Trust Co. has acquired 21,725 shares of Mondelez International (MDLZ) in the second quarter, valued at approximately $1.26 million, contributing to the 78.32% institutional ownership of the stock. Analysts generally maintain a "Moderate Buy" rating with an average target price of $67.30, …
Charles Schwab Trust Co Purchases New Holdings in RTX Corporation $RTX
Charles Schwab Trust Co. has acquired 5,282 shares of RTX Corporation, valued at approximately $1.0 million, during the second quarter, making it a new position for the institutional investor. RTX Corporation recently reported strong quarterly earnings, beating analyst estimates with $1.89 adjusted EPS and …
Charles Schwab Trust Co Increases Stock Position in Amgen Inc. $AMGN
Charles Schwab Trust Co significantly increased its stake in Amgen Inc. by 678.3% in the second quarter, now holding 7,464 shares valued at $2.7 million. This comes as institutional investors collectively own 76.5% of Amgen's stock, and the company reported strong quarterly earnings, beating …
Charles Schwab Trust Co Acquires 15,704 Shares of Philip Morris International Inc. $PM
Charles Schwab Trust Co significantly increased its stake in Philip Morris International (PM) by 636.8% in the second quarter, purchasing 15,704 additional shares, bringing its total holdings to 18,170 shares valued at $3.29 million. Philip Morris reported strong quarterly results, surpassing expectations with an …
Charles Schwab Trust Co Buys 97,424 Shares of ExxonMobil Corporation $XOM
Charles Schwab Trust Co significantly increased its stake in ExxonMobil Corporation (NYSE:XOM) by 392.9% in the second quarter, purchasing an additional 97,424 shares and bringing its total holdings to 122,223 shares valued at $16.71 million. Institutional investors now own 61.80% of ExxonMobil's stock. The …
Invesco QQQ $QQQ Shares Purchased by Charles Schwab Trust Co
Charles Schwab Trust Co significantly increased its holdings in Invesco QQQ (NASDAQ:QQQ) by 85.6% in the second quarter, bringing its total to 9,175 shares valued at $6.757 million. Other institutional investors also made substantial changes to their QQQ holdings, with Bank of America Corp …
Richardson Electronics, Ltd. $RELL Position Lessened by Dimensional Fund Advisors LP
Dimensional Fund Advisors LP reduced its stake in Richardson Electronics (NASDAQ:RELL) by 7.6% in the first quarter, now holding 715,503 shares valued at $7.84 million. Despite this, other institutional investors have increased their positions, and 71.95% of the stock is institutionally owned. The company …
Charles River Laboratories International, Inc. (NYSE:CRL) Given Average Recommendation of "Moderate Buy" by Brokerages
Charles River Laboratories International (NYSE:CRL) has received an average "Moderate Buy" rating from sixteen brokerages, with an average 12-month price target of $255.65. This follows the company exceeding quarterly earnings expectations with an adjusted EPS of $3.02 and revenue of $1.0 billion. Despite recent …
Schwab chief risk officer Nigel Murtagh sells $2.9m in stock
Nigel J. Murtagh, Chief Risk Officer at Charles Schwab Corp., recently sold approximately $2.9 million worth of company stock through a pre-arranged trading plan. These sales followed his exercise of nonqualified stock options totaling over $1.2 million, after which he retains a significant holding …
Charles Schwab (NYSE:SCHW) Director Sells 5,263 Shares of Stock
Charles Schwab (NYSE:SCHW) Director Paula Sneed sold 5,263 shares of the company's stock for approximately $563,930 on August 7th, reducing her position by 5.43%. Following the sale, she retained 91,711 shares. The company recently reported strong quarterly earnings, exceeding analyst estimates, and declared a …
Nigel Murtagh Sells 24,778 Shares of Charles Schwab (NYSE:SCHW) Stock
Charles Schwab insider Nigel Murtagh sold 24,778 shares of company stock for approximately $2.70 million. This transaction reduced his ownership by nearly 30% and was conducted under a pre-arranged Rule 10b5-1 plan. Despite the insider sale, Charles Schwab reported strong quarterly earnings, beating analyst …
SCHWAB CHARLES CORP (SCHW) insider Charles R. Schwab gifts 37,200 shares via trust
Charles R. Schwab, Co-Chairman of SCHWAB CHARLES CORP (SCHW), reported a bona fide gift transfer of 37,200 common stock shares on August 6, 2026. This transaction, made indirectly through a Trust, reflects his resignation as trustee of two trusts benefiting relatives. Following the gift, …
Schwab director Paula Sneed sells $563,954 in common stock By Investing.com
Paula A Sneed, a director at Charles Schwab Corp. (NYSE:SCHW), recently sold 5,263 shares of company stock for approximately $563,954. The sale occurred in multiple trades with prices ranging from $107.07 to $107.205 per share, as Schwab's stock trades near its 52-week high. Following …
Charles Schwab (SCHW) risk chief sells 26,675 shares after option exercise
Nigel J. Murtagh, Chief Risk Officer at Charles Schwab, exercised nonqualified stock options for 26,675 shares at $46.81 per share and subsequently sold them at an average of $109 per share on August 6 and 10, 2026. These transactions, which generated an approximate pre-tax …
ChargePoint Holdings, Inc. (CHPT) Sees a More Significant Dip Than Broader Market: Some Facts to Know
In the latest close session, ChargePoint Holdings, Inc. (CHPT) was down 1.61% at $6.12. The stock fell short of the S&P 500, which registered a loss of 0.06% for the day. At the same time, the Dow lost 0.11%, and the tech-heavy Nasdaq lost …
Victoria Creamer Sells 4,179 Shares of Charles River Laboratories International (NYSE:CRL) Stock
Victoria Creamer, EVP of Charles River Laboratories International (NYSE:CRL), sold 4,179 shares for over $1.08 million, reducing her holdings by 12.21%. Despite the insider sale, the company recently reported strong quarterly earnings, beating estimates with $3.02 EPS and $1 billion in revenue, and analysts …
Michael Gunnar Knell Sells 6,645 Shares of Charles River Laboratories International (NYSE:CRL) Stock
Michael Gunnar Knell, Chief Accounting Officer at Charles River Laboratories International (NYSE:CRL), recently sold 6,645 shares of the company's stock for approximately $1.73 million, reducing his stake by 35.92%. Despite this insider selling, the company reported strong quarterly earnings, beating analyst estimates, and has …
Charles River (CRL) finance chief sells 6,645 shares after exercising 2,345 options
Michael Gunnar Knell, SVP of Finance and Chief Accounting Officer at Charles River Laboratories International, Inc. (CRL), reported exercising 2,345 stock options and selling 6,645 shares of common stock on August 6, 2026. The options were exercised at strike prices between $179.66 and $208.44, …
James Foster (CRL) files Form 144 for 28,733-share option sale
James Foster, an insider at Charles River Laboratories International, Inc. (CRL), has filed a Form 144 indicating his plan to sell 28,733 shares of common stock. These shares will be acquired through the exercise of stock options for cash on August 10, 2026, with …
Charles River (CRL) EVP Victoria Creamer exercises options and sells 4,179 shares
Victoria L. Creamer, EVP & Chief People Officer of Charles River Laboratories International, Inc. (CRL), exercised stock options for 4,179 shares at $179.66 per share and immediately sold them for $259.16 per share on August 6, 2026. This transaction resulted in approximately $332K pre-tax …
Standard Chartered predicts 2,300% upside for LINK
Standard Chartered initiated coverage of Chainlink's native token, LINK, with an extremely bullish price target on Aug. 10. Chainlink is a decentralized blockchain oracle network that is used to facilitate the transfer of data from off-chain sources to on-chain smart contracts. LINK is a …
Chartwell Retirement Residences (TSX:CSH.UN) Stock Looks Stretched Despite Strong Q2 Results
Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Chartwell Retirement Residences has delivered a strong 135.2% return over the past three years, yet its current checks suggest the stock now leans expensive …
Schwab Trading Activity Index up modestly in July (SCHW:NYSE)
The Charles Schwab Corporation's trading activity index (STAX) showed a modest increase in July, rising to 59.80 from 59.12 in June. Schwab clients were net buyers of ETFs and equities at a two-to-one ratio, indicating continued bullish sentiment among self-directed traders.
Linqto Continues to Pursue Litigation Against Forge and Schwab to Recover Millions of Dollars in Damages to More than 13,000 Linqto Customers
Company Also Moving Forward With Risk Mitigation Strategies to Exit Bankruptcy as Quickly as Possible SAN JOSE, Calif. & HOUSTON, August 10, 2026--(BUSINESS WIRE)--Linqto, Inc. today announced that it continues to pursue its litigation against Forge Global, Inc. and its owner, The Charles Schwab …
Sharemaestro market context Trend signal started 52 weeks +3.6% · Next-week setup negative 43.7%Schwab Clients Buy Late-July Dips Across Stocks, ETFs and Options
The Schwab Trading Activity Index™ (STAX) increased to 59.80 in July, up slightly from June's 59.12, indicating that Schwab clients were net buyers during late-month market dips. Gen X clients and self-directed traders showed the strongest buying interest, focusing on individual stocks, ETFs, and …
Schwab Trading Activity Index™: STAX Score Increases Modestly in July
Schwab Trading Activity Index vs. S&P 500 (Graphic: Charles Schwab) Schwab clients were net buyers, using late-month dips to add exposure across individual stocks, ETFs, and options Key Takeaways: The Schwab Trading Activity Index™ (STAX) increased to 59.80 in July, up slightly from its …
Sharemaestro market context Trend signal started 52 weeks +3.6% · Next-week setup negative 43.7%International Markets and Charles River (CRL): A Deep Dive for Investors
Have you looked into how Charles River Laboratories (CRL) performed internationally during the quarter ending June 2026? Considering the widespread global presence of this medical research equipment and services provider, examining the trends in international revenues is essential for assessing its financial resilience and …
Charles River Laboratories , Inc. Stock 12‑Month Price Target Raised to $291.46, Implies 9% Upside
Analysts have raised the 12-month average price target for Charles River Laboratories International, Inc. (CRL) stock from $285.54 to $291.46, implying a 9% potential upside based on its August 7th closing price. The consensus rating from 19 analysts remains "Buy," with a majority recommending …